UPDATE: Important information about LabCorp's response to COVID-19 Read more >>>

News Releases

Webcast
Q3 2020 Laboratory Corporation of America Holdings Earnings Conference Call
Oct 27, 2020 at 9:00 AM EDT
Date Title and Summary Additional Formats
Sep 28, 2020
LabCorp to Announce Third Quarter Financial Results on October 27, 2020
  BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 28, 2020-- LabCorp (NYSE: LH) will release its third quarter of 2020 financial results before the market opens on Tuesday, Oct. 27, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.
Sep 28, 2020
LabCorp and GENFIT Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver Disease
LabCorp Contacts: Media: Donald Von Hagen — 336-436-8263 Media@LabCorp.com Investors: Clarissa Willett — 336-436-5076 Investor@LabCorp.com GENFIT Contacts: Media: Hélène Lavin — +3 33 2016 4000 Helene.Lavin@genfit.com Investors: Naomi Eichenbaum — 617-714-5252 Investors@genfit.com LabCorp and
Sep 23, 2020
New Non-Invasive Test for Lung Cancer Available Exclusively from LabCorp
Blood-based test guides treatment decisions for patients with non-small cell lung cancer BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 23, 2020-- LabCorp (NYSE:LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, has launched a new,
Sep 16, 2020
Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation
CHICAGO & BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 16, 2020-- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with
Sep 10, 2020
Labcorp Acquires Clinical Ambulatory Laboratory Business of Franciscan Missionaries of Our Lady Health System
  LabCorp Expands Services in Louisiana and Mississippi Through Acquisition and Creation of a Comprehensive Clinical Laboratory Relationship   BURLINGTON, N.C., Sept. 10, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care
Sep 08, 2020
LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season
Single Test Detects Multiple Respiratory Infections Including COVID-19 and Flu to Inform Treatment Options At-Home Use Through Pixel by LabCorp™   Pending FDA Authorization BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply
Sep 01, 2020
LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 1, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Baird’s 2020 Global Healthcare Conference on Wednesday, Sept. 9 at 11:25 a.m. ET .
Aug 11, 2020
LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation
No Charge Program Uses High-Affinity Test to Detect SARS-CoV-2 Antibodies BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 11, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing program
Jul 30, 2020
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
More details of the three-month program will be provided in the near future. BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 30, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total
Jul 28, 2020
LabCorp Announces 2020 Second Quarter Results
Q2 revenue of $2.8 billion , down (4%) from $2.9 billion last year Q2 diluted EPS of $2.37 , up 23% from $1.93 last year; Q2 adjusted EPS of $2.57 , down (12%) from $2.93 last year Q2 free cash flow of $272 million , up from $168 million last year Processed more than 8.5 million molecular COVID-19
Jul 25, 2020
LabCorp Receives Authorization for COVID-19 Sample Pooling
New Method Aims to Improve Efficiency of COVID-19 Testing, Optimize Testing Supplies and Increase Overall Capacity BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it
Jul 22, 2020
JLL and LabCorp team up to enable safer, healthier workplaces
LabCorp’s Employer Services wellness screenings support effective workplace re-entry and management CHICAGO, July 22, 2020 – Health, safety and wellness are top of mind for employers as they bring workers back to the office while navigating dynamic local conditions.
Jul 09, 2020
LabCorp’s Insight Analytics Reports Help Healthcare Organizations Identify Trends for High-Risk Health Conditions and Improve Quality of Care
Reports utilize LabCorp testing data related to conditions that have co-morbidities with other serious diseases, including increased COVID-19 risk BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company deeply integrated in guiding patient care,
Jul 07, 2020
LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience
Convenient LabCorp At Home Service Aims to Help Patients Resume Health Care, Treatments, and Surgeries BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 7, 2020-- LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping
Jul 06, 2020
LabCorp to Announce Second Quarter Financial Results on July 28, 2020
BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2020-- LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.
Jun 29, 2020
LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution
Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 29, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient
Jun 25, 2020
LabCorp Launches New Neutralizing Antibody Test
Neutralizing Antibody Assay Could Be Used to Assist in Development of COVID-19 Vaccines and Plasma-Based Treatments BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced the
Jun 16, 2020
Brian Caveney, Chief Medical Officer and President of LabCorp Diagnostics, Named to Modern Healthcare's 50 Most Influential Clinical Executives List
BURLINGTON, N.C., June 16, 2020 — LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Dr. Brian Caveney, chief medical officer and president of LabCorp Diagnostics, was recognized by Modern Healthcare as one of this
Jun 01, 2020
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials
Streamlining recruitment into studies to speed research BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 1, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, has created COVID-19
May 28, 2020
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of
May 19, 2020
Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US
LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June INDIANAPOLIS , May 19, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY ) today announced its Elecsys® Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab
May 14, 2020
LabCorp Launches Return to Work Services for Employers
Employers Now Have Access to LabCorp’s High-Quality COVID-19 Testing Capabilities Including Its New Fingerstick Antibody Blood Test BURLINGTON, N.C. --(BUSINESS WIRE)--May 14, 2020-- LabCorp (NYSE: LH) announced today it is launching a new return to work service for employers. Many U.S.
May 12, 2020
LabCorp Significantly Expands Availability of Its COVID-19 At-Home Collection Test Kit
Consumers Now Have Access to the At-Home Test Collection Kit Online with No Upfront Costs, In Addition to Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding
May 06, 2020
LabCorp Is Scheduled to Present at the Bank of America Securities 2020 Health Care Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--May 6, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Bank of America Securities 2020 Health Care Conference on Wednesday, May 13 , at 10:20 a.m. ET .
May 05, 2020
COVID-19 Antibody Test Now Directly Available Through LabCorp.com
Expanding Access to Tests Through LabCorp’s Wide Network of Doctors, Healthcare Providers, and Now Online BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that its COVID-19